“Effectiveness of Erythropoiesis-Stimulating Agent Therapy With Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients”. JURNAL FARMASIMED (JFM), vol. 9, no. 1, Oct. 2026, pp. 499-07, https://doi.org/10.35451/jfm.v9i1.3691.